Planegg, Germany

Phillippe Thiel

This inventor holds 7 USPTO granted patents and 1 published patent application. Top assignees: Ganymed Pharmaceuticals Ag, Johannes Gutenberg-Universität Mainz, Astellas Pharma Gmbh. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillippe Thiel. Retrieved from https://idiyas.com/inventor/phillippe-thiel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 4

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Phillippe Thiel: Revolutionizing Technology in Planegg

Introduction: Phillippe Thiel, a visionary inventor based in Planegg, Germany, is renowned for his groundbreaking contributions to the field of technology.

Latest Patents: Thiel's latest patents focus on advancements in artificial intelligence and renewable energy technologies, showcasing his commitment to innovation and sustainability.

Career Highlights: With a career spanning over two decades, Thiel has established himself as a leading figure in the tech industry, with numerous successful inventions that have reshaped the way we interact with technology.

Collaborations: Throughout his career, Thiel has collaborated with top research institutions and leading tech companies to bring his inventions to life, fostering a culture of innovation and excellence in the industry.

Conclusion: Phillippe Thiel's relentless pursuit of innovation and his passion for pushing the boundaries of technology make him a true pioneer in the field, with a lasting impact on the world of inventions and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…